PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Alice B Gottlieb Selected Research
TNFR-Fc fusion protein (etanercept)
01/2008
Etanercept treatment for children and adolescents with plaque psoriasis.
06/2007
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
05/2007
Mechanisms of action of etanercept in psoriasis.
11/2006
Ability to develop rhus allergic contact dermatitis in a patient with psoriasis receiving etanercept.
03/2006
Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.
01/2006
Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
01/2006
Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study.
07/2004
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.
01/2004
Etanercept for the treatment of psoriasis and psoriatic arthritis.
12/2003
A randomized trial of etanercept as monotherapy for psoriasis.
11/2003
Etanercept as monotherapy in patients with psoriasis.
Articles by Research Topic
Disease
41
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2008 - 05/2002
4
Psoriatic Arthritis
01/2006 - 09/2003
2
Atopic Dermatitis (Atopic Eczema)
09/2005 - 08/2005
1
Sclerosis
10/2008
1
Facial Paralysis (Facial Palsy)
06/2008
1
Syphilis
06/2008
1
Benign Familial Pemphigus (Hailey Hailey Disease)
07/2007
1
Allergic Contact Dermatitis
11/2006
1
Arthritis (Polyarthritis)
01/2006
1
Mycosis Fungoides
07/2004
1
Acne Vulgaris
03/2004
Drug/Important Bio-Agent (IBA)
11
TNFR-Fc fusion protein (etanercept)
FDA Link
01/2008 - 11/2003
7
efalizumab
FDA Link
04/2006 - 05/2002
6
infliximab (Remicade)
FDA Link
01/2007 - 01/2003
5
alefacept (Amevive)
FDA Link
01/2008 - 11/2003
3
Interleukin-12 (IL 12)
IBA
05/2007 - 12/2004
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2003 - 12/2002
2
pimecrolimus (Elidel)
FDA Link
09/2005 - 11/2004
2
Clobetasol (Clobetasol Propionate)
FDA Link
Generic
07/2004 - 05/2003
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
10/2008
1
imatinib (Gleevec)
FDA Link
10/2008
1
Acitretin
FDA Link
07/2007
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
04/2007
1
Chemokines
IBA
10/2006
1
Cytokines
IBA
10/2006
1
Tacrolimus (Prograf)
FDA Link
08/2005
1
adjuvant P40 (P 40)
IBA
12/2004
1
galiximab
IBA
04/2004
1
Cholestenone 5 alpha-Reductase (5 alpha-Reductase)
IBA
03/2004
1
Prostaglandins A (PGA)
IBA
06/2003
1
Proteins (Proteins, Gene)
IBA
11/2002
Therapy/Procedure
2
Climatotherapy
07/2004 - 09/2003
1
Aftercare (After-Treatment)
06/2008
1
Biological Therapy
07/2006
1
Immunotherapy
01/2004